The Risk of Quinolones in Hemodialysis

Fluoroquinolone antibiotics are widely prescribed in the US despite a growing number of serious adverse effects associated with their use. One of these adverse effects is QTc prolongation which can lead to lethal arrhythmias. A recent study evaluates in patients on hemodialysis are at an even higher risk.

Redeem your CPE or CME credit here!

• Pharmacist members
• CME

Need a membership?

• Join for CPE Credit 
• Join for CME Credit 

References and resources: Assimon MM, Pun PH, Wang L, et al. Analysis of Respiratory Fluoroquinolones and the Risk of Sudden Cardiac Death Among Patients Receiving Hemodialysis. JAMA Cardiol. Published online October 20, 2021. doi:10.1001/jamacardio.2021.4234

Continuing Education Information:

Learning Objectives: 

1. Describe the design and outcomes of a recent study that examines sudden cardiac death in a cohort of hemodialysis patients receiving quinolones
2. Apply the results of this study to a specific patient case

0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-21-389-H01-P
Initial release date: 12/06/21
Expiration date: 12/06/21
Additional CPE & CME details can be found here

Follow CEimpact on Social Media:
LinkedIn
Instagram